EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis

Esther T Mamo iD, Georgina M Newbold iD, Shelby C Moorehead

Veterinary Ophthalmology · 2024

DOI: 10.1111/vop.13168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2024. Verfasst von Esther T Mamo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Olopatadine Hydrochloride, Conjunctivitis, Allergic, Dog Diseases, Ophthalmic Solutions. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of the study was to evaluate the efficacy of a once a day, over the counter antihistamine eye drop, 0.7% olopatadine hydrochloride, in treating or preventing experimentally induced allergic conjunctivitis in dogs. Animals studied Twelve systemically healthy pet dogs with no known history of allergies or atopic dermatitis, and in the past 12 months had no known ocular abnormalities. Procedures Dogs were randomly assigned to two groups: “Treatment” which received topical 0.7% olopatadine hydrochloride and “Control” which received artificial tears. Dogs received the antihistamine eye drops before (Phase 1) or after (Phase 2) receiving a compounded ophthalmic histamine solution to induce clinical signs of allergic conjunctivitis. Conjunctival hyperemia, chemosis, follicles, ocular discharge, and ocular pruritus were graded, and photographs were used to document changes. Schirmer tear test values, fluorescein staining, and intraocular pressures were monitored throughout.

Results

In both Phase 1 and Phase 2, conjunctival scores increased 10 min after histamine administration ( p < .05). There was no difference between maximum overall conjunctival scores between treatment and control groups in either phase or when comparing treatment groups of Phase 1 to Phase 2 ( p > .05). However, treatment groups in Phase 2 did have a higher maximum conjunctival chemosis score and spent more time at their maximum chemosis score when compared to Phase 1 ( p < .05).

Conclusion

Olopatadine may be beneficial as prophylaxis to reduce the degree and duration of clinical signs of allergic conjunctivitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Olopatadine HydrochlorideConjunctivitis, AllergicDog DiseasesOphthalmic SolutionsAnimalsDogsFemaleMaleAnti-Allergic AgentsTreatment Outcome

Stichwörter der Autor:innen

H1 antagonistallergic conjunctivitisatopycanine allergieshistaminemast cell stabilizer

Substanzen

Olopatadine HydrochlorideOphthalmic SolutionsAnti-Allergic Agents

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Esther T Mamo, Georgina M Newbold

Zitieren

APA

Mamo, E. T., Newbold, G. M., & Moorehead, S. C. (2024). Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis. Veterinary Ophthalmology. https://doi.org/10.1111/vop.13168

Vancouver

Mamo ET, Newbold GM, Moorehead SC. Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis. Veterinary Ophthalmology. 2024. doi:10.1111/vop.13168

BibTeX
@article{Mamo2024,
  author = {Mamo, Esther T and Newbold, Georgina M and Moorehead, Shelby C},
  title = {Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis},
  journal = {Veterinary Ophthalmology},
  year = {2024},
  doi = {10.1111/vop.13168}
}
Kostenlos starten →